WebbSeries A - Ribometrix - 2024-11-13 - Crunchbase Funding Round Profile Funding Round Series A - Ribometrix Summary Overview Organization Name Ribometrix Announced … WebbRibometrix is a platform therapeutics company discovering small molecule drugs that target functional 3D RNA structures to treat human diseases. Our scientific offices are located in the newly...
Ribometrix Inc. LinkedIn
WebbDescription. Operator of a biotechnology company committed to pioneering a completely new class of small molecule therapeutics that modulate RNA (Ribonucleic acid) biology to treat human diseases. The company's three-dimensional structural analysis of RNA drives its discovery platform for the identification of novel small molecules that ... WebbSV Health Investors — DDF notes Ribometrix raises $7.8 Million in New Funding to Advance RNA-Targeting Drug Discovery Platform with Investment from DDF Choose the right … elliptically contoured distribution
Query Builder People Crunchbase
WebbRibometrix is a platform therapeutics company that discovers small molecule drugs that target functional 3D RNA structures to treat human diseases. Our scientific offices are … Ribometrix has raised a total of $45.3M in funding over 3 rounds. Their latest … Ribometrix is actively using 23 technologies for its website, according to BuiltWith. … Ribometrix has 4 current employee profiles, including Vice President, Lead Discovery … Ribometrix is a platform therapeutics company that discovers small molecule … WebbCrunchbase is the leading destination for company insights from early-stage startups to the Fortune 1000. Get insights into your competition. Uncover startup trends, get … Webb30 sep. 2024 · Ribometrix leverages its world-leading expertise in three-dimensional structural analysis of RNA to drive its discovery platform for the identification of novel small molecules that modulate the function of RNA … elliptically polarized undulator